Records containing: Prostatic Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-16Lymphedema in the Lower Extremities After Urologic Surgery With Lymph Node Dissection
-
CLINICAL_TRIALS study record update · 2026-01-15Canary Prostate Active Surveillance Study
-
CLINICAL_TRIALS study record update · 2026-01-15A Phase I, Multicentre, Open-label, First-in-Human, Dose Escalation and Expansion Study of DM002 in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-01-14uPAR in Blood From Zytiga® (Abiraterone) Treated Patients With Castration Resistant Prostate Cancer - a Predictive Marker of Response?
-
CLINICAL_TRIALS study record update · 2026-01-08A Randomized Phase 2 Study of Cabozantinib (XL184) in Combination With Abiraterone in Chemotherapy Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer (CRPC)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-07Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
-
CLINICAL_TRIALS study record update · 2025-12-31Novel Hormonal Therapies (NHTs) for the Treatment of Metastatic Castration-sensitive Prostate Cancer (mCSPC) in the Medicare Population
-
CLINICAL_TRIALS study record update · 2025-12-22A Phase 1, Multi-center, Open-label, Dose Finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Cc-94676 in Subjects With Metastatic Castration-resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-12-15The Registry to Observe Clinical Outcomes of Patients With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
-
CLINICAL_TRIALS study record update · 2025-12-12A Phase II Trial of Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy
-
CLINICAL_TRIALS study record update · 2025-12-12Medico-economic Comparison of Robot-assisted Radical Prostatectomy Using the da Vinci System Versus Radical Prostatectomy Via Laparotomy
-
CLINICAL_TRIALS study record update · 2025-12-10An Open-Label Expanded Access Protocol for Apalutamide Treatment of Subjects With Non Metastatic Castration-Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-12-05Phase 2 Trial Pembrolizumab or Pembrolizumab in Combination With Intratumoral SD-101 Therapy in Patients With Hormone-Naïve Oligometastatic Prostate Cancer Receiving Stereotactic Body Radiation Therapy and Intermittent Androgen Deprivation Therapy
-
CLINICAL_TRIALS study record update · 2025-11-28A Prospective Observational Study on the Effect of Changes in Endotracheal Tube Cuff Pressure on Postoperative Pharyngolaryngeal Complications in Patients Undergoing Robot-Assisted Radical Prostatectomy
-
CLINICAL_TRIALS study record update · 2025-11-24Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression
-
CLINICAL_TRIALS study record update · 2025-11-21Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-11-20Validation of a Semiquantitative Screening Assay for PSA
-
CLINICAL_TRIALS study record update · 2025-10-09PSMAfore: A Phase III, Open-label, Multi-Center, Randomized Study Comparing 177Lu-PSMA-617 vs. a Change of Androgen Receptor-Directed Therapy in the Treatment of Taxane Naïve Men With Progressive Metastatic Castrate Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-10-09PSMAfore: A Phase III, Open-label, Multi-Center, Randomized Study Comparing 177Lu-PSMA-617 vs. a Change of Androgen Receptor-Directed Therapy in the Treatment of Taxane Naïve Men With Progressive Metastatic Castrate Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-10-02PROWESS (PROstate Cancer Wearables Exercise and Structured Supports): A Pilot Supportive Care Intervention
-
CLINICAL_TRIALS study record update · 2025-09-12Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance
-
CLINICAL_TRIALS study record update · 2025-08-29Evaluation of Atherosclerotic Plaques in Abdominal CT Studies
-
CLINICAL_TRIALS study record update · 2025-08-29A Phase I/IIa Theranostic Study of 64Cu-SAR-BBN and 67Cu-SAR-BBN for Identification and Treatment of GRPR-expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617
-
CLINICAL_TRIALS study record update · 2025-08-11RecoverPC: A Phase 2 Study of RElugolix Versus GnRH Agonist Quality of Life (QOL) and Testosterone reCOVERy in Men With Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-08-08A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Darolutamide in Addition to Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Men With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)